LUCA Science Raises ¥3.86 Billion ($30.3 Million) in Oversubscribed Series B Financing
TOKYO--(BUSINESS WIRE)--LUCA Science, a global innovator in the development of a novel class of mitochondria biopharmaceutical agents, today announced the closing of a ¥3.86 billion (USD 30.3 million) oversubscribed Series B financing. The round was co-led by DCI Partners, 4BIO Capital and existing investor Fast Track Initiative and supported by...
